首页> 中文期刊>中国药房 >双黄连与 3种不同药物配伍前、后微粒的变化

双黄连与 3种不同药物配伍前、后微粒的变化

     

摘要

OBJECTIVE: To observe the changes of insoluble particles of shuanghuanglian in quantity after mixed with benzylpenicillin,cefradine and dexamethasone in normal saline.METHODS: Using ZWF-4D particle counter,the number of insoluble particles in sizes of ≥ 2.0μ m,≥ 5.0μ m,≥ 10.0μ m and ≥ 25.0μ m was counted and compared before and after mixed with above-mentioned three drugs.RESULTS: The insoluble particles of Shuanghuanglian were obviously increased after mixed with benzylpenicillin,the particles in sizes of ≥ 5.0μ m,≥ 10.0μ m and ≥ 25.0μ m increased twice,23 and 94 times respectively.The insoluble particles were also increased after mixed with cefradine or dexamethasone,however,the increase rate was lower in comparison with that mixed with benzylpenicillin.CONCLUSION: Shuanghuanglian,used in combination with above-mentioned drugs,should be put into separate infusion bottle to avoid the increase of insoluble particles and ADRs.%目的:考察双黄连与青霉素、头孢拉定、地塞米松 3种不同注射剂配伍前、后的不溶性微粒变化。方法:利用 ZWF-4D型注射液微粒分析仪分别计数双黄连与 3种注射剂配伍前后≥ 2 0、≥ 5 0、≥ 10 0和≥ 25 0μ m的微粒数,并进行比较。结果:双黄连与青霉素配伍后的不溶性微粒数明显多于配伍前,≥ 5 0μ m、≥ 10 0μ m、≥ 25μ m分别增加 2、 23、 94倍,而头孢拉定、地塞米松与双黄连配伍后的不溶性微粒也明显多于配伍前,但低于青霉素与双黄连配伍后的不溶性微粒数。结论:临床在用双黄连与这些药物联合应用时,宜分别放入 2个输液瓶内应用,以避免不溶性微粒数的增加及不良反应发生率的上升。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号